Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2012
03/22/2012WO2012037543A1 Host supported genetic biosensors
03/22/2012WO2012037413A2 Systems and methods for biotransformation of carbon dioxide into higher carbon compounds
03/22/2012WO2012037324A2 Increasing carbon flow for polyhydroxybutyrate production in biomass crops
03/22/2012WO2012037254A1 MODIFIED iRNA AGENTS
03/22/2012WO2012037123A1 Microbes, methods, and devices for redox-imbalanced metabolism
03/22/2012WO2012037107A1 Compositions and methods for xylem-specific expression in plant cells
03/22/2012WO2012036993A1 Computationally optimized broadly reactive antigens for influenza
03/22/2012WO2012036884A2 Bioproduction of aromatic chemicals from lignin-derived compounds
03/22/2012WO2012036507A2 Aptazyme specifically releasing antisense against microrna in hcv-infected cells, and use thereof
03/22/2012WO2012036437A2 Immunogenic peptide and composition having the peptide for preventing or treating hpv-related disease
03/22/2012WO2012036410A2 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
03/22/2012WO2012036392A2 Human anti-epidermal growth factor receptor fab antibody and a pharmaceutical composition for treating tumours comprising the same
03/22/2012WO2012036391A2 Surface expression vector of porcine circovirus type 2 (pcv2) gene and salmonella vaccine strain transformed with same
03/22/2012WO2012036350A1 Method for detecting target mrna of synthesized micro-rna
03/22/2012WO2012036329A1 Composition or kit for making a prognosis of liver cancer, and method for making a prognosis of liver cancer
03/22/2012WO2012036302A1 Process for producing vinylglycine derivatives
03/22/2012WO2012036301A1 Process for producing vinylglycine derivatives
03/22/2012WO2012036290A1 Method for cultivating lilies containing delphinin in the petals thereof
03/22/2012WO2012036259A1 Model animal for studying hair growth cycle
03/22/2012WO2012036241A1 Novel extracellularly secreted nuclease
03/22/2012WO2012036215A1 Inhibitor of hmgb protein-mediated immune response activation, and screening method
03/22/2012WO2012036211A1 Skin activation by means of pdgf-bb activity enhancement
03/22/2012WO2012036151A1 Sulfur amino acid-producing bacteria and method for producing sulfur amino acids
03/22/2012WO2012036111A1 Primer, probe, and method for multi-specimen analysis
03/22/2012WO2012035115A1 A raft deficient yeast expression system for the production of recombinant membrane proteins
03/22/2012WO2012035088A1 Na+/Mg2+ exchanger
03/22/2012WO2012035066A1 Hot1 and uses thereof
03/22/2012WO2012035050A2 Factor viii variants having a decreased cellular uptake
03/22/2012WO2012035034A1 Serpin-finger fusion polypeptide
03/22/2012WO2012034969A1 Gt aptamer oligonucleotides and use thereof as antitumor agents
03/22/2012WO2012034942A1 Compounds for the modulation of aurora kinase b expression
03/22/2012WO2012034865A1 Methods for increasing the size of plants or plant organs
03/22/2012WO2012034532A1 Hereditary spinocerebellar ataxia-related gene and use thereof
03/22/2012WO2012034197A1 Synthetic gene for expressing sm-14 in pichia pastoris, methods for producing and purifying sm-14 and the use thereof as a vaccine and diagnostic medium
03/22/2012WO2012013823A3 A yeast artificial chromosome carrying the mammalian glycosylation pathway
03/22/2012WO2012007965A8 Enzyme for the production of optically pure 3 - quinuclidinol
03/22/2012WO2011153440A3 Transposon mutagenesis system and methods of use
03/22/2012WO2011153323A3 Compositions and methods directed to treating liver fibrosis
03/22/2012WO2011145915A3 Modified polyhedrin, and polyhedras and biotechnological products obtained from same
03/22/2012WO2011139846A3 Compositions and methods for reduced scarring and for treatment of fibrosis
03/22/2012WO2011120474A9 Method for inhibiting hiv replication in mammal and human cells
03/22/2012WO2011116088A9 Compositions and methods for the detection of genomic features
03/22/2012WO2011112845A3 Methods and compositions related to a multi-methylation assay to predict patient outcome
03/22/2012WO2005032457A3 Vectors and methods for immunization against norwalk virus using transgenic plants
03/22/2012US20120073019 Yield Enhancement in Plants by Modulation of a ZM-CIPK1 Protein
03/22/2012US20120073018 Jatropha curcas curcin genes, tissue-specific promoters and generation of curcin-deficient transgenic jatropha plants
03/22/2012US20120073017 Method for producing chrysanthemum plant having petals containing modified anthocyanin
03/22/2012US20120073016 Axmi-150 delta-endotoxin gene and methods for its use
03/22/2012US20120073015 Methods for plant transformation using spectinomycin selection
03/22/2012US20120073014 Zantedeschia Variety 110167-55633
03/22/2012US20120073013 Lettuce variety paulita (ls9498)
03/22/2012US20120073012 Lettuce variety carini (ls9499)
03/22/2012US20120073002 Prevention and treatment of blood coagulation-related disases
03/22/2012US20120073001 Methods and compositions for treating or preventing pruritis
03/22/2012US20120072120 Automatic threshold setting and baseline determination for real-time pcr
03/22/2012US20120071859 Inducible interleukin-12
03/22/2012US20120071645 Tetrahydropyran nucleic acid analogs
03/22/2012US20120071631 Isolation and Characterization of Novel Green Fluorescent Proteins from Copepods
03/22/2012US20120071546 Novel Glutamic Acid Decarboxylase (GAD) Chimera And Methods Of Use
03/22/2012US20120071545 Compositions and methods for treatment of bacterial and mycobacterial infections
03/22/2012US20120071436 Method, composition and kit for antigenic binding of norwalk-like viruses
03/22/2012US20120071419 Target-Specific Non-Antibody Protein and Method for Preparing the Same
03/22/2012US20120071415 Dominant negative mutants of sam68 for use in the treatment of spinal muscular atrophy (sma)
03/22/2012US20120071395 TREATMENT OF MAMMALIAN PHYSIOLOGICAL REACTION OF IgE ANTIBODIES PRESENT IN SAID MAMMAL UPON CONTACT WITH THE CORRESPONDEING ANTIGEN
03/22/2012US20120071394 Novel polypeptides and use thereof
03/22/2012US20120071361 Substrate Preparation Process
03/22/2012US20120071348 Methods for large scale functional evaluation of nucleotide sequences in plants
03/22/2012US20120071344 Compositions and methods for identifying enzyme and transport protein inhibitors
03/22/2012US20120070900 T-dna/protein nano-complexes for plant transformation
03/22/2012US20120070899 Effective vector platform for gene transfer and gene therapy
03/22/2012US20120070894 Thermophilic and thermoacidophilic sugar transporter genes and enzymes from alicyclobacillus acidocaldarius and related organisms, methods
03/22/2012US20120070893 Methods for producing nonadherent avian cell lines
03/22/2012US20120070892 DNA Virus MicroRNA and Methods for Inhibiting Same
03/22/2012US20120070891 Inhibition-based high-throughput screen strategy for cell clones
03/22/2012US20120070890 Targeted gene modification by parvoviral vectors
03/22/2012US20120070881 Bacillus licheniformis chromosome
03/22/2012US20120070876 Variant form of urate oxidase and use thereof
03/22/2012US20120070871 Polypeptide having d-lactate dehydrogenase activity, polynucleotide encoding the polypeptide, and process for production of d-lactic acid
03/22/2012US20120070868 Production of odd chain fatty acid derivatives in recombinant microbial cells
03/22/2012US20120070863 Novel beta-galactoside-alpha2,3-sialyltransferase, a gene encoding thereof, and a method for producing thereof
03/22/2012US20120070826 Lafora's disease gene
03/22/2012US20120070824 Thermostable proteinases from thermophilic bacteria
03/22/2012US20120070819 Determination of Interactions of Constant Parts of Antibodies with FC-Gamma Receptors
03/22/2012US20120070486 Methods and compositions related to prefoldin and its regulation
03/22/2012US20120070460 Dendritic cell modulatory molecule
03/22/2012US20120070456 Polypeptide carrier protein
03/22/2012US20120070454 Dengue vaccine, pharmaceutical composition comprising the same, nucleotide sequence and antibody composition
03/22/2012US20120070447 Methods of administering / dosing anti-rsv antibodies for prophylaxis and treatment
03/22/2012US20120070446 Rsv specific binding molecule
03/22/2012US20120070439 Antigen-binding proteins
03/22/2012US20120070437 Method of identifying compounds that bind baff-r
03/22/2012US20120070436 Antigen-binding proteins
03/22/2012US20120070435 Chimeric antigens for eliciting an immune response
03/22/2012US20120070419 Method of altering the differentiative state of a cell and compositions thereof
03/22/2012DE19735587B4 Peptid mit radioprotektiver Wirkung, dieses enthaltende kosmetische oder pharmazeutische Zusammensetzung, für dieses kodierende Nukleinsäure, Herstellungsverfahren für dieses Peptid und die Verwendung als radioprotektives Agens Peptide having radioprotective effect, cosmetic or pharmaceutical composition containing it, for this coding nucleic acid, production processes for this peptide and use as radioprotektives agent
03/22/2012DE102007020302B4 Verbesserte dreidimensionale biokompatible Gerüststruktur, die Nanopartikel beinhaltet Improved three-dimensional biocompatible scaffold structure, the nanoparticles includes
03/22/2012CA2848656A1 Systems and methods of delivery of bioactive agents using bacterial toxin-derived transport sequences
03/22/2012CA2812046A1 Modified irna agents
03/22/2012CA2811538A1 Na+/mg2+ exchanger
03/22/2012CA2811501A1 Inhibitor of hmgb protein-mediated immune response activation, and screening method